Causal Flows
are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators
and regulons
. In the causal flow, a mutation
may causally activate or deactivate a downstream regulator which then might up- down-regulates a regulon that contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows regulated by Mutation PCDHB13_code_potential_somatic
ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
---|---|---|---|---|---|---|---|---|
CMF-17700 | PCDHB13 | down-regulates | ARID5B | activates | R-3006 | 4 | 2 | Drugs (33) Regulator Drugs (0)Regulon Drugs (33)SAVOLITINIB, TELISOTUZUMAB VEDOTIN, AMUVATINIB, CABOZANTINIB, ALTIRATINIB, SGX-523, TEREVALEFIM, TEPOTINIB HYDROCHLORIDE, FORETINIB, ONARTUZUMAB, SAR-125844, AMG-208, MK-8033, AMG-337, CAPMATINIB HYDROCHLORIDE, AMIVANTAMAB, MK-2461, MERESTINIB, BMS-777607, CAPMATINIB, JNJ-38877605, GLESATINIB, BMS-817378, CABOZANTINIB S-MALATE, CRIZOTINIB, EMD-1204831, TIVANTINIB, TELISOTUZUMAB, TEPOTINIB, EMIBETUZUMAB, BPI-9016, PF-04217903, GOLVATINIB |
CMF-17710 | PCDHB13 | down-regulates | NR3C1 | activates | R-2049 | 21 | 7 | Drugs (1) |
CMF-17727 | PCDHB13 | up-regulates | HLX | activates | R-3583 | 10 | 3 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-17728 | PCDHB13 | up-regulates | HLX | represses | R-3585 | 10 | 3 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-17740 | PCDHB13 | up-regulates | E2F1 | activates | R-537 | 18 | 5 | Drugs (1) |
CMF-17751 | PCDHB13 | up-regulates | FOXC2 | represses | R-2652 | 11 | 6 | Drugs (1) |
CMF-17754 | PCDHB13 | up-regulates | FOXC2 | represses | R-2644 | 11 | 6 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |